PARATHYROID HORMONE (PTH) A new class of osteoporosis treatments called bone formation agents Parathyroid hormone analogues belong to a class of osteoporosis medications which can promote bone growth. In Canada, […]

National E-Newsletter Sign up now to receive Osteoporosis Canada’s National Newsletter Osteoporosis Canada’s national e-communications showcase current organizational developments, updates on osteoporosis and bone health, new initiatives and more.

GET SUPPORT Support Resources Osteoporosis Canada currently produces publications in various languages. LEARN MORE Let’s Talk The information line gives you access to trained and compassionate staff and volunteers who […]

Vitamin D plays a significant role in building and maintaining healthy bones. In light of the current COVID-19 pandemic, the effects of vitamin D on the immune system are being […]

Due to the current COVID situation, more whole birds are available to consumers and knowing that you have options is important when making food decisions when making grocery purchases. Most […]

Menopause is associated with a range of symptoms which may affect quality of life as well may increase an individual’s risk of chronic conditions such as osteoporosis or cardiovascular disease.  […]

As we work to adjust to our new normal during COVID-19, now more than ever, staying fracture-free is critical for anyone with osteoporosis. Healthcare systems are over-stretched, with general recommendations […]

FRAX In addition to femoral neck (hip) BMD, age, gender, fracture history and steroid use, FRAX also takes into account other clinical risk factors to calculate the absolute 10-year risk […]

Osteoporosis is a chronic condition that, if you are at high risk of fracture, requires treatment with an osteoporosis medication. There is currently no evidence that osteoporosis medications increase the […]